SG49230A1 - Vectors expressing of human interferon for the treatment of AIDS - Google Patents

Vectors expressing of human interferon for the treatment of AIDS

Info

Publication number
SG49230A1
SG49230A1 SG1996008025A SG1996008025A SG49230A1 SG 49230 A1 SG49230 A1 SG 49230A1 SG 1996008025 A SG1996008025 A SG 1996008025A SG 1996008025 A SG1996008025 A SG 1996008025A SG 49230 A1 SG49230 A1 SG 49230A1
Authority
SG
Singapore
Prior art keywords
aids
treatment
human interferon
vectors expressing
expressing
Prior art date
Application number
SG1996008025A
Other languages
English (en)
Inventor
Majid Mehtali
Philippe Leissner
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of SG49230A1 publication Critical patent/SG49230A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1996008025A 1993-12-13 1994-12-13 Vectors expressing of human interferon for the treatment of AIDS SG49230A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9314915A FR2713657B1 (fr) 1993-12-13 1993-12-13 Nouveaux vecteurs pour le traitement du sida.

Publications (1)

Publication Number Publication Date
SG49230A1 true SG49230A1 (en) 1998-05-18

Family

ID=9453844

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008025A SG49230A1 (en) 1993-12-13 1994-12-13 Vectors expressing of human interferon for the treatment of AIDS

Country Status (7)

Country Link
EP (1) EP0682712A1 (ja)
JP (1) JPH08506970A (ja)
AU (1) AU1275195A (ja)
CA (1) CA2155568A1 (ja)
FR (1) FR2713657B1 (ja)
SG (1) SG49230A1 (ja)
WO (1) WO1995016784A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997032983A1 (en) * 1996-03-05 1997-09-12 The Regents Of The University Of California Recombinant live feline immunodeficiency virus and proviral dna vaccines
WO1998000542A2 (en) * 1996-07-03 1998-01-08 Chiron Corporation Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia
US6696423B1 (en) 1997-08-29 2004-02-24 Biogen, Inc. Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
WO2001057204A1 (fr) * 2000-02-02 2001-08-09 Yasufumi Kaneda Vecteur d'enveloppe virale pour transfert de gene
US11325948B2 (en) 2016-03-19 2022-05-10 Exuma Biotech Corp. Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
JP7108551B2 (ja) * 2016-03-19 2022-07-28 エクスマ バイオテック コーポレイション リンパ球に形質導入を行うための方法及び組成物、並びにその制御された増加

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA08768A (fr) * 1986-10-22 1989-03-31 Schering Corp Traitement du virus su SIDA par l'interféron alpha humain recombinant.
WO1990011359A1 (en) * 1989-03-20 1990-10-04 Whitehead Institute For Biomedical Research Intracellular method of inhibiting hiv in mammalian cells
ATE188125T1 (de) * 1991-10-25 2000-01-15 Sidney Kimmel Cancer Ct Lymphokine gentherapie bei krebs in kombination mit tumorantigenen

Also Published As

Publication number Publication date
JPH08506970A (ja) 1996-07-30
AU1275195A (en) 1995-07-03
EP0682712A1 (fr) 1995-11-22
FR2713657A1 (fr) 1995-06-16
FR2713657B1 (fr) 1996-03-01
CA2155568A1 (fr) 1995-06-22
WO1995016784A1 (fr) 1995-06-22

Similar Documents

Publication Publication Date Title
ZA941773B (en) Therapeutic uses of bactericidal/permeability increasing protein products
EP0728202A4 (en) EPISOMIC EXPRESSION VECTOR FOR HUMAN GENE THERAPY
ZA936865B (en) Osteosynthesis aid
HU9503451D0 (en) The treatment of small animals
HU9400942D0 (en) The treatment of meat
GB9304746D0 (en) Treatment of viral infections
ZA935347B (en) Treatment of solid material
SG49230A1 (en) Vectors expressing of human interferon for the treatment of AIDS
GB9222260D0 (en) Skin treatment
GB9313556D0 (en) Synthetic peptides of human papillomavirus
GB9024860D0 (en) Treatment of dispersions
GB9217124D0 (en) Medical treatment
AU4319393A (en) Use of indolocarbazols in aids treatment
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
GB9412915D0 (en) Synthetic peptides of human papillomavirus
GB9400600D0 (en) Treatment of motion seckness
ZA954563B (en) Electrolytic treatment of material
GB9218773D0 (en) Skin treatment
GB9216360D0 (en) Treatment of blood
EG21036A (en) Medical treatment for aids
GB9007251D0 (en) Treatment of aids
GB9019293D0 (en) Treatment of aids
GB2306096B (en) The treatment of small animals
ZA951440B (en) Novel opiold peptides for the treatment of pain and use thereof
KR960004832Y1 (en) Medical crutch